Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Atmar

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Vaccine Immunology : CVI|August 13, 2010
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemicH M El Sahly, S M Patel, R L Atmar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 20, 2015
Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant RecipientsX Ye, J N Van, F M Munoz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adultsJ A Englund, R E Champlin, P R Wyde, et al.
Pediatrics|November 1, 1983
Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infantsL H Taber, V Knight, B E Gilbert, et al.
Annals of Internal Medicine|January 15, 1991
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials NetworkR Dolin, B S Graham, S B Greenberg, et al.
Vaccine|September 6, 2001
Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccineR L Jones, J E Froeschle, R L Atmar, et al.
Transactions of the Association of American Physicians|January 1, 1983
Ribavirin aerosol treatment of influenza B virus infectionH W McClung, V Knight, B E Gilbert, et al.
Applied and Environmental Microbiology|January 1, 1996
Collaborative evaluation of a method for the detection of Norwalk virus in shellfish tissues by PCRR L Atmar, F H Neill, C M Woodley, et al.
Vaccine|July 2, 2009
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humansH M El Sahly, R L Atmar, S M Patel, et al.
The Journal of Infectious Diseases|April 8, 2000
A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparationN A Daniels, D A Bergmire-Sweat, K J Schwab, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Vaccine Immunology : CVI|August 13, 2010
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemicH M El Sahly, S M Patel, R L Atmar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 20, 2015
Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant RecipientsX Ye, J N Van, F M Munoz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adultsJ A Englund, R E Champlin, P R Wyde, et al.
Pediatrics|November 1, 1983
Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infantsL H Taber, V Knight, B E Gilbert, et al.
Annals of Internal Medicine|January 15, 1991
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials NetworkR Dolin, B S Graham, S B Greenberg, et al.
Vaccine|September 6, 2001
Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccineR L Jones, J E Froeschle, R L Atmar, et al.
Transactions of the Association of American Physicians|January 1, 1983
Ribavirin aerosol treatment of influenza B virus infectionH W McClung, V Knight, B E Gilbert, et al.
Applied and Environmental Microbiology|January 1, 1996
Collaborative evaluation of a method for the detection of Norwalk virus in shellfish tissues by PCRR L Atmar, F H Neill, C M Woodley, et al.
Vaccine|July 2, 2009
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humansH M El Sahly, R L Atmar, S M Patel, et al.
The Journal of Infectious Diseases|April 8, 2000
A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparationN A Daniels, D A Bergmire-Sweat, K J Schwab, et al.
Pageof 7